Optimizing Drug & CDx Development with Liquid CGP Under the Regulatory Requirements in Japan

• Challenges in developing LBx as CDx
• Considerations for clinical trial design with LBx development
• Points for the timing of drug and CDx development in Japan

Speakers:

Chiaki Kiyokawa

PHC Solution, Regulatory Affairs Group

Chugai Pharmaceuticals